🇺🇸 FDA
Pipeline program

Traditional Chinese Medicine Prescription

2020XLA015-1

Phase 3 small_molecule active

Quick answer

Traditional Chinese Medicine Prescription for COVID-19 is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
COVID-19
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials